CERo Therapeutics Announces Receipt of Nasdaq Panel Determination
CERo Therapeutics Announces Receipt of Nasdaq Panel Determination GlobeNewswire October 29, 2025 Trading of the Company's shares of common stock on Nasdaq will be suspended at the open of trading on October 31 CERo plans to appeal the Panel determination, seek trading of its shares on the OTC Markets and continue clinical operations SOUTH SAN […]